As a result, the liposome platform holds tremendous promise in the future of targeted cancer therapeutics to improve drug delivery while minimizing unwanted systemic bystander effects. This review ...

CNW/ -- (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and ...

InnoCan Pharma ( ($TSE:INNO) ) has issued an announcement. Innocan Pharma’s subsidiary, BI Sky Global, has completed the Human Repeated Insult ...

Nanotechnology, a groundbreaking field that involves manipulating matter at the molecular and atomic levels, is rapidly ...

liposome properties, such as size, surface charge and functionality, can be easily tuned. Polymeric nanocarriers can be categorized based on three drug-incorporation mechanisms. The first includes ...

To take advantage of the characteristics of these innate immune cells, researchers at China Pharmaceutical University encased paclitaxel, a traditional chemotherapy drug, with lipids. These liposome ...

Revium Rx Shifts Focus with Acquisition of LipoVation Ltd., Advancing Nanoparticle-Based Drug DevelopmentIsrael, Feb. 04, ...

I then worked within a newly established Drug Delivery Company (Lipoxen Technologies Ltd) for two years, developing their liposome drug delivery platform technology before moving into Academia to set ...

Significant growth trajectory of the Breast Cancer Application segment, which is expected to reach US$374.1 Million by 2030 ...